
Article 1 
The approval of the active substance glyphosate, as specified in Annex I, is renewed subject to the conditions laid down in that Annex.
Article 2 
The Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with Annex II to this Regulation.
Article 3 
This Regulation shall enter into force on the day following that of its publication in the Official Journal of the European Union.
It shall apply from 16 December 2017.
This Regulation shall be binding in its entirety and directly applicable in all Member States.Done at Strasbourg, 12 December 2017.
For the Commission
The President
Jean-Claude JUNCKER
ANNEX I

Common Name,Identification Numbers IUPAC Name Purity Date of approval Expiration of approval Specific provisions
GlyphosateCAS No 1071-83-6CIPAC No 284 N-(phosphonomethyl)glycine ≥ 950 g/kgImpurities:Formaldehyde, less than 1 g/kgN-Nitroso-glyphosate, less than 1 mg/kg 16 December 2017 15 December 2022 Only uses as herbicide may be authorised.For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on glyphosate, and in particular Appendices I and II thereof, shall be taken into account.In this overall assessment Member States shall pay particular attention to:
— the protection of the groundwater in vulnerable areas, in particular with respect to non-crop uses,
— the protection of operators and amateur users,
— the risk to terrestrial vertebrates and non-target terrestrial plants,
— the risk to diversity and abundance of non-target terrestrial arthropods and vertebrates via trophic interactions,
— compliance of pre-harvest uses with good agricultural practices.Conditions of use shall include risk mitigation measures, where appropriate.Member States shall ensure that use of plant protection products containing glyphosate is minimised in the specific areas listed in Article 12(a) of Directive 2009/128/EC.Member States shall ensure equivalence between the specifications of the technical material, as commercially manufactured, and those of the test material used in the toxicological studies.Member States shall ensure that plant protection products containing glyphosate do not contain the co-formulant POE-tallowamine (CAS No 61791-26-2).

ANNEX II

The Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:

((1)) in Part A, entry 25 on glyphosate is deleted;
((2)) in Part B, the following entry is added:

 Common Name,Identification Numbers IUPAC Name Purity Date of approval Expiration of approval Specific provisions
‘118 GlyphosateCAS No 1071-83-6CIPAC No 284 N-(phosphonomethyl)glycine ≥ 950 g/kgImpurities:Formaldehyde, less than 1 g/kgN-Nitroso-glyphosate, less than 1 mg/kg 16 December 2017 15 December 2022 Only uses as herbicide may be authorised.For the implementation of the uniform principles, as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on glyphosate, and in particular Appendices I and II thereof, shall be taken into account.In this overall assessment Member States shall pay particular attention to:
— the protection of the groundwater in vulnerable areas, in particular with respect to non-crop uses,
— the protection of operators and amateur users,
— the risk to terrestrial vertebrates and non-target terrestrial plants,
— the risk to diversity and abundance of non-target terrestrial arthropods and vertebrates via trophic interactions,
— compliance of pre-harvest uses with good agricultural practices.Conditions of use shall include risk mitigation measures, where appropriate.Member States shall ensure that use of plant protection products containing glyphosate is minimised in the specific areas listed in Article 12(a) of Directive 2009/128/EC.Member States shall ensure equivalence between the specifications of the technical material, as commercially manufactured, and those of the test material used in the toxicological studies.Member States shall ensure that plant protection products containing glyphosate do not contain the co-formulant POE-tallowamine (CAS No 61791-26-2).

